Prostate Cancer Chemotherapy
Chemotherapy is used for advanced, metastatic prostate cancer. It uses drugs to directly kill cancer cells. Some forms of chemotherapy can be administered orally, while others are only administered intravenously or by injection into muscle tissue. Chemotherapy is used in advanced prostate cancer, after hormonal therapy has failed.
The most commonly used chemotherapeutic agents used to fight prostate cancer include:
- Docetaxel (Taxotere)
- Estramustine (Emcyt)
- Mitoxantrone (Novantrone)
- Paclitaxel (Taxol)
- Cabazitaxel (Jevtana)
Continue to Prostate Cancer Cryotherapy
- Alibhai SM, Klotz LH. A systematic review of randomized trials in localized prostate cancer. Can J Urol. 2004 Feb;11(1):2110-7. 
- Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control. 2004 May;15(4):367-86. 
- Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int. 2004 May;93(8):1139-50. 
- Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003 Jun;91(9):789-94. 
- Mahmud S, Franco E, Aprikian A. Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. Br J Cancer. 2004 Jan 12;90(1):93-9.